Top story

CPHI Milan: Why One Reliable Supplier Isn't Enough

Read full story

FDA approves AbbVie’s upadacitinib for giant cell arteritis

Pharmaceutical Technology
By gullapalli - Wed, 30 Apr 2025
Read more

Trump’s first 100 days tout US-bound pharma investments amid tariff worries

Pharmaceutical Technology
By Manasi Vaidya - Wed, 30 Apr 2025
Read more

Impending US tariffs signal uncertain future for global pharma, says GlobalData

Pharmaceutical Technology
By GlobalData Healthcare - Wed, 30 Apr 2025
Read more

AstraZeneca’s Truqap fails in another Phase III trial

Pharmaceutical Technology
By Abigail Beaney - Wed, 30 Apr 2025
Read more